Dual immunotherapy with neoadjuvant chemotherapy shows encouraging activity in ERBB2-negative breast cancerJuly 30, 2026
Tech FTC sues Hims & Hers, alleging it breached patient privacyBy Healthcare Propulsion StaffJuly 29, 20260 The Federal Trade Commission, along with Utah and California authorities, sued telehealth company Hims & Hers, alleging it misled consumers…
